| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 227,558 | 213,168 | 199,231 | 190,683 | | Cost of Revenue | 126,007 | 118,534 | 111,805 | 108,302 | | | Gross Profit | 101,551 | 94,634 | 87,426 | 82,381 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 55,993 | 53,825 | 49,553 | 55,477 | | Non Recurring |
-
| (220) | (5,833) | 2,343 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 45,558 | 41,029 | 43,706 | 24,561 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,837 | 3,290 | (3,190) | 1,825 | | Earnings Before Interest And Taxes | 48,395 | 44,319 | 40,516 | 26,386 | | Interest Expense | 22,256 | 15,912 | 13,451 | 14,744 | | Income Before Tax | 26,139 | 28,407 | 27,065 | 11,642 | | Income Tax Expense | 7,327 | 10,967 | 11,608 | (104,857) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,812 | 17,440 | 15,457 | 116,499 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,812 | 17,440 | 15,457 | 116,499 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,812 | $17,440 | $15,457 | $116,499 |
|
1.06% Nasdaq 
Income Statement
